Emergent Biosolutions
(EBS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 308,718 | 214,841 | 216,515 | 280,499 | 242,249 |
| Receivables | 60,470 | 112,860 | 81,082 | 60,191 | 52,373 |
| Inventories | 80,070 | 84,708 | 82,134 | 65,674 | 62,533 |
| Income taxes - deferred | 1,483 | 1,483 | 1,656 | 1,710 | N/A |
| TOTAL | $473,490 | $435,488 | $405,811 | $432,175 | $383,632 |
| Non-Current Assets | |||||
| PPE Net | 327,643 | 320,084 | 315,489 | 313,979 | 304,211 |
| Intangibles | 112,323 | 114,695 | 98,186 | 110,929 | 105,765 |
| Other Non-Current Assets | 63,092 | 73,056 | 98,359 | 81,608 | 75,683 |
| TOTAL | $503,058 | $507,835 | $512,034 | $506,516 | $485,659 |
| Total Assets | $976,548 | $943,323 | $917,845 | $938,691 | $869,291 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 2,488 |
| Accounts payable and accrued liabilities | 41,248 | 41,824 | 40,583 | 40,930 | 39,351 |
| Accrued Expenses | 34,303 | 32,762 | 25,424 | 37,928 | 31,538 |
| Other current liabilities | 4,440 | 5,033 | 9,024 | 8,733 | 2,139 |
| TOTAL | $88,725 | $86,962 | $80,297 | $92,936 | $81,417 |
| Non-Current Liabilities | |||||
| Long Term Debt | 253,000 | 253,000 | 251,000 | 251,000 | 251,000 |
| Deferred Revenues | 8,734 | 7,343 | 5,266 | 5,345 | 5,813 |
| Other Non-Current Liabilities | 23,524 | 35,027 | 42,864 | 35,841 | 17,921 |
| TOTAL | $282,511 | $294,110 | $299,670 | $292,554 | $274,736 |
| Total Liabilities | $371,236 | $381,072 | $379,967 | $385,490 | $356,153 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 38,943 | 38,800 | 38,357 | 37,918 | 37,552 |
| Common Shares | 39 | 39 | 38 | 38 | 38 |
| Retained earnings | 317,792 | 280,850 | 266,749 | 288,269 | 258,152 |
| Other shareholders' equity | -4,472 | -3,977 | -3,562 | -3,328 | -3,929 |
| TOTAL | $605,312 | $562,251 | $537,878 | $553,201 | $513,138 |
| Total Liabilities And Equity | $976,548 | $943,323 | $917,845 | $938,691 | $869,291 |